The study is a Comparative Clinical and Biochemical Study Evaluating the effect of Proton Pump Inhibitors versus histamine 2 Receptor antagonists as an adjuvant with chemotherapy in patients with Non-hodgkin Lymphoma to compare the difference in efficacy.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
DLBCL Lymphoma subtype --No comorbid disease
You may not be if
Pregnancy
Peptic ulcer
Severe cardiac disease
Osteoporosis
Clareo Health | PPI Versus Histamine Antagnists as Adjuvant to Chemotherapy
